This protocol is judged by an institutional critique board, an impartial team that testimonials any clinical trials involving humans. If a study will involve a Schedule I drug, when the board approves the protocol as ethical, the researchers really have to submit an application for an investigational new drug (IND) selection within the FDA.If This